Disc Medicine Inc
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
IRON$81.26+3.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| | December 31,2024 | December 31,2023 | |
|---|---|---|---|
| Assets · | |||
| Current assets: · | |||
| Cash and cash equivalents | | $192,434 | $360,382 |
| Marketable securities | 297,447 | — | |
| Prepaid expenses and other current assets | | 3,734 | 5,280 |
| Total current assets | | 493,615 | 365,662 |
| Property and equipment, net | | 751 | 170 |
| Right-of-use assets, operating leases | | 1,569 | 1,930 |
| Other assets | | 838 | 234 |
| Total assets | | $496,773 | $367,996 |
| Liabilities and Stockholders’ Equity | | ||
| Current liabilities: | | ||
| Accounts payable | | $7,948 | $12,629 |
| Accrued external research and development expenses | 7,141 | 1,986 | |
| Other accrued expenses | | 8,097 | 6,159 |
| Operating lease liabilities, current | | 130 | 665 |
| Total current liabilities | | 23,316 | 21,439 |
| Long-term debt, net | 28,322 | — | |
| Operating lease liabilities, non-current | | 1,548 | 1,436 |
| Total liabilities | | 53,186 | 22,875 |
| Commitments and contingencies (Note 15) | | ||
| Stockholders’ equity: | | ||
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized, no shares issued or outstanding as of December 31, 2024 and December 31, 2023 | — | — | |
| Common stock, $0.0001 par value; 100,000,000 shares authorized as of December 31, 2024 and December 31, 2023; 29,865,030 and 24,360,233 shares issued and outstanding as of December 31, 2024 and December 31, 2023, respectively | | 3 | 2 |
| Additional paid-in capital | | 741,297 | 533,764 |
| Accumulated other comprehensive income | 289 | — | |
| Accumulated deficit | | (298,002) | (188,645) |
| Total stockholders’ equity | | 443,587 | 345,121 |
| Total liabilities and stockholders’ equity | | $496,773 | $367,996 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.